What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Why Thermo Fisher Scientific (NASDAQ: TMO) is spending US$9.4bn on Clario to dominate clinical-trial analytics Find out how Thermo Fisher’s US$9.4 billion acquisition of Clario is reshaping the clinical-trial services industry and what it means for investors. byPallavi MadhirajuOctober 30, 2025